119 related articles for article (PubMed ID: 20958142)
1. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor.
Berlinski A; Hayden JB
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):397-404. PubMed ID: 20958142
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
Waldrep JC; Berlinski A; Dhand R
J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
[TBL] [Abstract][Full Text] [Related]
3. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
Berg E; Svensson JO; Asking L
J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
Kwong WT; Ho SL; Coates AL
J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
[TBL] [Abstract][Full Text] [Related]
5. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nebulizer performance under various humidity conditions.
Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of positive expiratory pressure devices attached to nebulizers.
Berlinski A
Respir Care; 2014 Feb; 59(2):216-22. PubMed ID: 23920213
[TBL] [Abstract][Full Text] [Related]
8. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
Abdelrahim ME
Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
[TBL] [Abstract][Full Text] [Related]
9. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.
Zhou Y; Brasel TL; Kracko D; Cheng YS; Ahuja A; Norenberg JP; Kelly HW
Pharm Dev Technol; 2007; 12(4):353-9. PubMed ID: 17763140
[TBL] [Abstract][Full Text] [Related]
10. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
11. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output.
Berlinski A; Waldrep JC
J Aerosol Med; 2006; 19(4):484-90. PubMed ID: 17196077
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic charge characteristics of jet nebulized aerosols.
Kwok PC; Trietsch SJ; Kumon M; Chan HK
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
[TBL] [Abstract][Full Text] [Related]
13. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
Rao N; Kadrichu N; Ament B
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
[TBL] [Abstract][Full Text] [Related]
14. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
Johnson JC; Waldrep JC; Guo J; Dhand R
Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
[TBL] [Abstract][Full Text] [Related]
15. Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines.
Leung K; Louca E; Gray M; Tipples G; Coates AL
J Aerosol Med; 2005; 18(4):414-26. PubMed ID: 16379617
[TBL] [Abstract][Full Text] [Related]
16. Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.
Abdelrahim ME; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):19-28. PubMed ID: 19392586
[TBL] [Abstract][Full Text] [Related]
17. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
[TBL] [Abstract][Full Text] [Related]
18. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy.
Berlinski A
Respir Care; 2013 Dec; 58(12):2076-86. PubMed ID: 23674810
[TBL] [Abstract][Full Text] [Related]
19. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients.
Awad SM; Berlinski A
Respir Care; 2018 Mar; 63(3):294-300. PubMed ID: 29432139
[TBL] [Abstract][Full Text] [Related]
20. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
